Preparation of radioactive praseodymium oxide as a multifunctional agent in nuclear medicine: Expanding the horizons of cancer therapy using nanosized neodymium oxide

Nuclear Medicine Communications

Volumn 34, Issue 1, 2013, Pages 5-12

  Bakht, Mohamadreza K ^a   Sadeghi, Mahdi ^c   Ahmadi, Seyed J ^b   Sadjadi, Sodeh S ^b   Tenreiro, Claudio ^d,e  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b NUCLEAR SCIENCE AND TECHNOLOGY RESEARCH INSTITUTE   (Iran)

^c AGRICULTURAL MEDICAL AND INDUSTRIAL RESEARCH SCHOOL   (Iran)

^d UNIVERSIDAD DE TALCA   (Chile)

^e Sungkyunkwan University   (South Korea)

Author keywords

Autophagy; Cancer therapy; Nano praseodymium oxide; Non small cell lung cancer; Poly(ethylene glycol); Radioisotope production

Indexed keywords

MACROGOL; NANOPARTICLE; NEODYMIUM; NEODYMIUM OXIDE; PRASEODYMIUM OXIDE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; WATER;

ARTICLE; AUTOPHAGY; CALCULATION; CANCER THERAPY; DRUG SOLUBILITY; MATHEMATICAL MODEL; NEUTRON RADIATION; PARTICLE SIZE; RADIOACTIVITY; STOICHIOMETRY; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

HUMANS; NANOSTRUCTURES; NEODYMIUM; NEOPLASMS; NEUTRONS; NUCLEAR MEDICINE; OXIDES; PRASEODYMIUM; RADIOCHEMISTRY; RADIOISOTOPES; RADIOPHARMACEUTICALS; SOLUBILITY; TEMPERATURE; WATER;

EID: 84870884988     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32835aa7bd     Document Type: Article

References (31)

1. Liu S. Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides. Adv Drug Deliv Rev 2008; 60:1347-1370.
2. Kassis AI. Therapeutic radionuclides: biophysical and radiobiologic principles. Semin Nucl Med 2008; 38:358-366.
3. Qaim SM. Therapeutic radionuclides and nuclear data. Radiochim Acta 2001; 89:297-302.
4. 142Pr radionuclide therapy. Ann Nucl Med 2012; 26:412-418.
5. 142Pr microspheres as a potential treatment for arteriovenous malformations. Phys Med Biol 2005; 50:151-166.
6. 142Pr glass seeds for brachytherapy. Appl Radiat Isot 2008; 66:441-449.
7. 143Pr for radionuclide therapy (RNT) applications. In: Proceedings of the 5th International Conference on Isotopes (5ICI). Brussels, Belgium; 2005. pp. 103-107.
8. 142Pr]- DTPA for application in radionuclide therapy. In: Proceedings of the 5th International Conference on Isotopes (5ICI). Brussels, Belgium; 2005. pp. 521-526.
9. 142Pr hydroxyapatite crystals: a potential therapeutic agent for radiosynovectomy. Indian J Nucl Med 2002; 17:7-8.
10. Bakht MK, Sadeghi M. Internal radiotherapy techniques using radiolanthanide praseodymium-142: a review of production routes, brachytherapy, unsealed source therapy. Ann Nucl Med 2011; 25:529-535.
11. Qaim SM. Radiochemical determination of nuclear data for theory and applications. J Radioanal Nucl Chem 2010; 284:489-505.
12. 137mCe. J Radioanal Nucl Chem 2012; 292:53-59.
13. m,g to evaluate experimental cross section data. Phys Rev C 2012; 85:0346051-0346057.
14. Koning AJ, Duijvestijn MC. New nuclear data evaluations for Ge isotopes. Nucl Instrum Methods Phys Res B 2006; 248:197-224.
15. Sublet JC, Packer LW, Kopeckyl J, Forrest RA, Koning AJ, Rochman DA. The European Activation File (EAF). Neutron-induced cross section library: Issue 1. EASY Documentation Series CCFE-R (10) 05; 2010. Available at: http://www.ccfe.ac.uk/EASY-data/eaf2010/Docs/EAF-n-Cross-sections-2010.pdf [Accessed April 2010].
16. Hosseini SA, Vosoughi N, Hosseini M. Monte Carlo simulation of Feynman-α and Rossi-α techniques for calculation of kinetic parameters of Tehran Research Reactor. Ann Nucl Energy 2011; 38:2140-2214.
17. 198Au reaction. J Radioanal Nucl Chem 2012; 293:45-49.
18. IAEA. IAEA-TECDOC-1340, Manual for reactor produced radioisotopes. ISBN: 92-0-101103-2, ISSN 1011-4289. Vienna: IAEA 2003; Available at: http://www.isotopes.gov/outreach/reports/Reactor-Isotopes.pdf [Accessed January 2003].
19. 142Pr: a potential for therapeutic applications and biodistribution studies. J Radioanal Nucl Chem 2011; 288:937-942.
20. Experimental Nuclear Reaction Data. EXFOR: database version of 3 October 2011. Available at: http://www.nds.iaea.org/exfor/exfor.htm [Accessed October 2011].
21. American Cancer Society. Lung and bronchus. Cancer facts and figures. 2012; Atlanta, GA: American Cancer Society. pp. 15-16.
22. Chen Y, Yang L, Feng C, Wen LP. Nano neodymium oxide induces massive vacuolization and autophagic cell death in non-small cell lung cancer NCI-H460 cells. Biochem Biophys Res Commun 2005; 337:52-60.
23. Di Pasqua AJ, Miller ML, Lu X, Peng L, Jay M. Tumor accumulation of neutron-activatable holmium-containing mesoporous silica nanoparticles in an orthotopic non-small cell lung cancer mouse model. Inorg Chim Acta (in press). doi:10.1016/j.ica.2012.06.016.
24. Li J, Kao WJ. Synthesis of polyethylene glycol (PEG) derivatives and PEGylated-peptide biopolymer conjugates. Biomacromolecules 2003; 4:1055-1067.
25. Bhatia S, Mohr A, Mathur D, Parmar VS, Haag R, Prasad AK. Biocatalytic route to sugar-PEG-based polymers for drug delivery applications. Biomacromolecules 2011; 12:3487-3498.
26. Francesco MV, Gianfranco P. PEGylation, successful approach to drug delivery. Drug Discov Today 2005; 10:1451-1458.
27. Ishii T, Otsuka H, Kataoka K, Nagasaki Y. Preparation of functionally Pegylated gold nanoparticles with narrow distribution through autoreduction of auric cation by alpha-biotinyl-PEG-block-[poly(2-(N,Ndimethylamino) ethyl methacrylate)]. Langmuir 2004; 20:561-564.
28. Kannan R, Zambre A, Chanda N, Kulkarni R, Shukla R, Katti K, et al. Functionalized radioactive gold nanoparticles in tumor therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2012; 4:42-51.
29. International Atomic Energy Agency. Cyclotron produced radionuclides: principles and practice, technical report. Series No. 465. Vienna: IAEA; 2008.
30. National Research Council and Institute of Medicine Committee. National Research Council (US) and Institute of Medicine (US) Committee on State of the Science of Nuclear Medicine. Advancing nuclear medicine through innovation. Washington, DC: National Academies Press; Available at: http://www.ncbi.nlm.nih. gov/books/NBK11472/; 2007.
31. Bakht MK, Sadeghi M, Pourbaghi-Masouleh M, Tenreiro C. Scope of nanotechnology-based radiation therapy and thermotherapy methods in cancer treatment. Curr Cancer Drug Targets 2012; 12:998-1015.